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Transferrin receptor expression is exclusive to the endothelial cells of the 
brain capillaries as opposed to endothelial cells in other organs of the body. 
This makes the transferrin receptor an interesting target for drug delivery to 
the brain. However, evidence on the intracellular trafficking mechanism of 
the transferrin receptor does not support the possibility of full transcytosis 
of the receptor. Still, the transferrin receptor could be an important tool to 
transport nanocarriers to the brain vasculature and subsequently depend on 
BCEC processing of the nanocarrier to mediate drug release. 
 
We studied transferrin receptor-targeted liposomes containing oxaliplatin as 
a model drug cargo with the aim of quantifying the nanocarrier and cargo 
uptake in BCECs and the remainder of the CNS. A parallel approach using 
both in vitro and in vivo assessments was employed to study this aspect. For 
in vitro studies, a primary culture model of the rat blood-brain barrier was 
used to study the uptake of the immunoliposomes. For in vivo studies, 18 
day old rats were used (due to their high expression of transferrin receptor 
on their brain capillaries) to study the passage of oxaliplatin into the brain 
parenchyma.  
 
The uptake of OX26-conjugated immunoliposomes by BCECs were 
significantly higher both in vitro and in vivo when compared to isotypic 
IgG-conjugated liposomes. Quantitative analyses after capillary depletion 
revealed cargo transport from BCECs to the remaining CNS, but no 
differences could be detected between OX26-conjugated and isotype IgG 
control immunoliposomes in vivo, whereas isotype IgG control 
immunoliposomes were superior in vitro. In conclusion, OX26-targeted 
immunoliposomes are suitable for uptake by BCECs, which may be 
exploited for controlled release of a drug compound within the BCEC. 
